Holt P G, Oliver J, Bilyk N, McMenamin C, McMenamin P G, Kraal G, Thepen T
Western Australian Research Institute for Child Health, Princess Margaret Hospital, Perth.
J Exp Med. 1993 Feb 1;177(2):397-407. doi: 10.1084/jem.177.2.397.
Class II major histocompatibility complex (Ia)-bearing dendritic cells (DC) from airway epithelium and lung parenchyma express low-moderate antigen presenting cell (APC) activity when freshly isolated. However, this function is markedly upregulated during overnight culture in a manner analogous to epidermal Langerhans cells. The in vitro "maturation" process is inhibited by coculture with pulmonary alveolar macrophages (PAM) across a semipermeable membrane, and the degree of inhibition achieved can be markedly increased by the presence of tumor necrosis factor alpha. In addition, PAM-mediated suppression of DC function is abrogated via inhibition of the nitric oxide synthetase pathway. Functional maturation of the DC is accompanied by increased expression of surface Ia, which is also inhibited in the presence of PAM. Prior elimination of PAM from DC donors via intratracheal administration of the cytotoxic drug dichloromethylene diphosphonate in liposomes, 24-72 h before lung DC preparation, achieves a comparable upregulation of APC activity, suggesting that (consistent with the in vitro data) the resident PAM population actively suppresses the APC function of lung DC in situ. In support of the feasibility of such a regulatory mechanism, electron microscopic examination of normal lung fixed by intravascular perfusion in the inflated state (which optimally preserves PAM in situ), revealed that the majority are preferentially localized in recesses at the alveolar septal junctions. In this position, the PAM are in intimate association with the alveolar epithelial surface, and are effectively separated by as little as 0.2 microns from underlying interstitial spaces which contain the peripheral lung DC population. A similar juxtaposition of airway intraepithelial DC is demonstrated with underlying submucosal tissue macrophages, where the separation between the two cell populations is effectively the width of the basal lamina.
来自气道上皮和肺实质的表达II类主要组织相容性复合体(Ia)的树突状细胞(DC)在刚分离时表现出低至中等水平的抗原呈递细胞(APC)活性。然而,在过夜培养期间,这种功能会以类似于表皮朗格汉斯细胞的方式显著上调。体外“成熟”过程通过与肺泡巨噬细胞(PAM)跨半透膜共培养而受到抑制,并且肿瘤坏死因子α的存在可显著增强抑制程度。此外,通过抑制一氧化氮合酶途径可消除PAM介导的DC功能抑制。DC的功能成熟伴随着表面Ia表达的增加,在PAM存在时这种表达也受到抑制。在制备肺DC前24 - 72小时,通过气管内给予脂质体包裹的细胞毒性药物二氯亚甲基二膦酸盐预先清除DC供体中的PAM,可实现类似的APC活性上调,这表明(与体外数据一致)驻留的PAM群体在原位积极抑制肺DC的APC功能。为支持这种调节机制的可行性,对处于膨胀状态下通过血管内灌注固定的正常肺进行电子显微镜检查(这种状态能最佳地原位保存PAM),结果显示大多数PAM优先定位在肺泡间隔连接处的凹陷处。在这个位置,PAM与肺泡上皮表面紧密相连,与含有外周肺DC群体的下方间质空间仅相隔0.2微米。气道上皮内DC与下方黏膜下组织巨噬细胞也呈现类似的并列关系,两个细胞群体之间的分隔实际上就是基膜的宽度。